The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 12, 2024

Filed:

Nov. 23, 2021
Applicant:

Proarc Medical Ltd., Misgav Business Park, IL;

Inventors:

Shai Golan, Kibbutz Megiddo, IL;

Raz Bar-On, Hadera, IL;

Boaz Harari, Ganei-Tikva, IL;

Yair Feld, Haifa, IL;

Assignee:

ProArc Medical Ltd., Misgav Business Park, IL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 17/32 (2006.01); A61B 90/00 (2016.01); A61F 2/04 (2013.01); A61M 29/00 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61M 25/04 (2006.01);
U.S. Cl.
CPC ...
A61B 17/320016 (2013.01); A61B 18/1492 (2013.01); A61B 90/39 (2016.02); A61F 2/04 (2013.01); A61M 29/00 (2013.01); A61B 2017/00274 (2013.01); A61B 2017/32007 (2017.08); A61B 2017/320071 (2017.08); A61B 2017/320082 (2017.08); A61B 2018/00285 (2013.01); A61B 2018/00547 (2013.01); A61B 2018/1412 (2013.01); A61B 2090/062 (2016.02); A61F 2002/048 (2013.01); A61M 25/04 (2013.01);
Abstract

Apparatus and methods are described for treatment of a urethra that is constricted due to benign prostatic hyperplasia (BPH). A positioning device is used to determine a location of the area of the urethra that is constricted and is to be treated. An execution device includes a dilation balloon, a cutter, an implant carrier, and an implant, the implant and the implant carrier both being disposed outside the outer surface of the dilation balloon. The urethra is dilated by expanding the dilation balloon, and a cut is formed in the inner surface of the urethra using the cutter. The implant is released into the cut within the inner surface of the urethra subsequent to the cutter forming the cut in the inner surface of the urethra, to thereby maintain the urethra in a dilated state. Other embodiments are also described.


Find Patent Forward Citations

Loading…